Pictet Asset Management (UK)’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$17.6M Buy
2021
Q1
$20M Hold
2020
Q4
$19.8M Buy
2020
Q3
$8.05M Buy